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Abstract
Cationic liposomes have been used successfully for DNA delivery to airway cells in vitro and are being tested in human
clinical trials for their efficacy in cystic fibrosis transmembrane conductance regulator (CFTR) gene delivery in cystic fibrosis
patients. While cationic liposomes are effective for transfection of airway cells in culture, they have not been effectively used
for gene delivery to human airway cells in vivo. Several barriers in cystic fibrosis lungs, including increased amounts of
mucus, phagocytic cell activity and cytokine-rich milieu caused by inflammation, may cause inhibition of gene transfection.
As presented in this paper, we examined the effects of inflammatory cytokines on cationic lipid-mediated transfection of
model airway cells. The results of these experiments indicate that tumor necrosis factor (TNF)-K dramatically inhibits
Lipofectin-mediated transfection efficiency of H441 cells. Addition of anti-TNF-K neutralizing antibody results in recovery
of efficiency. Results of temporal studies are consistent with the concept that TNF-K reduces transfection efficiency by a
mechanism(s) other than or in addition to gene expression. These results are corroborated by fluorescence microscopic
experiments which demonstrate that endocytosis of lipoplex is altered in the presence of TNF-K. ß 2001 Elsevier Science
B.V. All rights reserved.
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1. Introduction
E¡ective transfection of airway cells in vitro by
cationic liposomes (CLips) has demonstrated their
potential utility in gene correction of genetic lung
diseases such as cystic ¢brosis (CF). An advantage
of cationic liposomes is that they have been shown to
be non-toxic to animals [1,2]. CLip-mediated trans-
fection of normal and cystic ¢brosis transgenic
mouse lungs has demonstrated the e¡ectiveness of
these vehicles for DNA delivery in vivo [2^5]. How-
ever, the transfection e⁄ciency of lung epithelial cells
is dramatically reduced compared to similar in vitro
experiments. Subsequent human gene therapy trials,
studying safety and e⁄cacy of cationic lipids, have
shown that these delivery vehicles were not successful
in correcting ion transport in the nasal epithelia of
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CF patients [6]. As with adenoviral-mediated gene
therapy, the e⁄ciency of cationic liposome-mediated
transfection is likely to be dictated by barriers within
the lung environment resulting from in£ammation.
Therefore, it is necessary to examine this environ-
ment and determine the cause for reduced uptake
or expression of transgenes by the targeted cells.
In£ammation accompanying CF leads to a 10-fold
increase in pulmonary macrophages and a 1000-fold
increase in the polymorphonuclear neutrophil
(PMN) population [7]. Even in the very early stages
of CF in£ammation can be detected in the lungs. The
overwhelming population of cytokine producing cells
results in a milieu with increased levels of cytokines
such as tumor necrosis factor (TNF)-K and interleu-
kin (IL)-8 [8,9]. The broad range of activities of in-
£ammatory cytokines could pose a potential barrier
for e¡ective and e⁄cient gene transfer to airway
cells. For instance, TNF-K has been implicated in
the regulation of cellular uptake processes such as
phagocytosis in monocyte cell lines and transcytosis
in brain capillary endothelial cells [10,11]. TNF-K is
also involved in regulation of viral and non-viral
gene expression in a variety of cell types. Thus,
TNF-K or other in£ammatory cytokines could act
as a barrier to gene therapy if it were to control
uptake, routing or expression of delivered DNA.
Considering the roles of in£ammatory cytokines, it
was hypothesized that in£ammatory cytokines de-
crease DNA transfection by in£uencing cellular up-
take or expression of delivered DNA. The experi-
ments presented herein focus on determining the
in£uences of speci¢c cytokines, that are secreted by
activated alveolar macrophages or other cells during
in£ammation, on DNA transfection e⁄ciency of air-
way epithelial cells. Because of the relatively high
transfection e⁄ciency demonstrated for cationic lipo-
somes to deliver DNA to cells in vitro and the estab-
lished safety in vivo, Lipofectin was used as the mod-
el DNA delivery vehicle for transfection of airway
epithelial cells in the present in vitro studies.
2. Methods
2.1. Reporter gene constructs
PGL2 (Promega, Madison, WI) which encodes for
the luciferase gene and is driven by the SV40 pro-
moter, was used as the reporter gene for transfec-
tions of H441 cells in isolated culture. Co-culture
experiments utilized RSV/Cat, which encodes for
chloramphenicol acetyltransferase and is driven by
the Rous sarcoma virus early promoter.
2.2. Transfection protocol
Lipofectin (Gibco, Gaithersburg, MD) is a 1:1
(w/w) mixture of DOTMA (N-[1-(2,3-dioleoyloxy)-
propyl]-N,N,N-trimethylammonium chloride) and di-
oleoylphosphatidylethanolamine (DOPE). Lipofectin
has been used for in vitro and in vivo transfections,
and has both a similar mechanism of cellular uptake
and similar transfection e⁄ciencies (depending on
cell type) in comparison to other cationic lipid ad-
mixtures [12^14]. Complexes were formulated ac-
cording to the manufacturer’s recommendations. Ap-
prox. 2 pmol DNA and 10 Wg Lipofectin were used
to transfect cells at 60% con£uence in 60 mm culture
plates. Reporter DNA was added to 200 Wl serum-
free medium prior to combination with Lipofectin.
DME-F12 was used while testing conditioned macro-
phage medium, otherwise RPMI 1640 was used as
the transfection medium. DNA alone, Lipofectin
alone, or DNA-Lipofectin complex (henceforth re-
ferred to as lipoplex) were added dropwise to the
cells, and cultures were incubated at 37‡C for an
18 h period. After this transfection period, the cells
were washed with appropriate serum-free medium
and then incubated for an additional 24 h in appro-
priate medium with 10% FCS. After this period, cells
were harvested for reporter gene assay. Unless other-
wise noted all media and other chemicals were pur-
chased from Sigma (St. Louis, MO).
2.3. Macrophage isolation
Utilizing the techniques previously described, al-
veolar macrophages (AMs) were obtained from
whole rabbit lungs [15]. Following sacri¢ce by lethal
injection with pentobarbital, whole lungs were ex-
cised from adult male New Zealand white rabbits,
in accordance with a protocol approved by the In-
stitutional Animal Care and Use Committee of
MUSC. After the lavage procedure, cells were kept
at 4‡C and then centrifuged for 20 min at 1000Ug
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through a discontinuous Percoll gradient. AMs taken
from the 1.06 and 1.08 gm/dl gradients were sus-
pended in Hanks’ balanced salt solution 1U
(HBSS) and subsequently washed once. Cell viability
was assessed by 0.4% Trypan blue stain exclusion.
Viability per 100 cells typically averaged v 95%. As
previously demonstrated, the wild type alveolar mac-
rophage (wtAM) population obtained from adult
rabbit lungs by the same procedure used here is het-
erogeneous in that both (natively) inactive and active
AMs are present [15]. Macrophages were suspended
in DME-F12 medium without serum at a concentra-
tion of 1U106 cells/ml.
2.4. Conditioned macrophage medium
To obtain conditioned medium, unactivated AMs
(wild type or wtAMs) were incubated at a cell con-
centration of 1U106 cells/ml for 24 h, 37‡C in hu-
midi¢ed atmosphere of 5% CO2/95% air in the pres-
ence of (1) macrophage activator, either serum-
treated zymosan (STZ, 1 mg/ml), concanavalin A
(Con A, 10 ng/ml), or lipopolysaccharide (LPS,
100 ng/ml) to yield activated alveolar macrophages
(aAMs), or (2) cytokines, either TNF-K (0.2 ng/ml;
RpD Systems, Minneapolis, MN), or IL-6 (0.5 ng/ml;
RpD Systems) to yield cytokine-conditioned alveolar
macrophages (cytAMs), or (3) DME-F12 alone (con-
trol). STZ, Con A and LPS were added at concen-
trations previously shown to activate macrophages.
Conditioned media were collected and centrifuged at
600Ug to eliminate macrophage cells and other de-
bris. The medium was ¢lter-sterilized (0.22 Wm) and
combined with fresh DME-F12 in a 40:60 v/v ratio
[16].
2.5. Co-culture experiments
Co-culture experiments were performed with
wtAMs or Con A-activated aAMs (10 Wg Con
A/ml) initially incubated in serum-free DME-F12
for 24 h. Macrophages (wtAMs or aAMs) were
then isolated by centrifugation at 600Ug, suspended
in DME-F12 medium without serum at a concentra-
tion of 1U106 cells/ml, plated on inserts of 35 mm
transwell tissue culture dishes (Corning Glass Works,
Corning, NY) and incubated (37‡C in a humidi¢ed
atmosphere of 5% CO2/95% air) for 24 h in the pres-
ence of H441 cells (cultured on the bottom of the
transwells), as described below. H441 cells were
plated on the bottom of the 35 mm transwells, while
aAMs or wtAMs were seeded on the inserts. The
AM to H441 cell ratio used for co-culture experi-
ments was 10:1, which is physiologically relevant
with respect to a bacteria-compromised lung [17].
While a membrane with 3.0 Wm pores separates the
two cell populations, all media and other added
chemicals were shared.
2.6. Isolated H441 cell cultures
H441 cells are a human pulmonary adenocarcino-
ma cell line of epithelial origin. H441 cells were
maintained in either DME-F12 medium (experiments
with conditioned AM medium) or RPMI 1640 (direct
addition experiments) with 10% calf serum and
plated 2^3 days prior to transfection experiments
(4.5U105 cells seeded/60 mm plate). At approx.
60% con£uence, cells were washed and media
changed to respective serum-free media in prepara-
tion for transfection.
To examine the in£uence of macrophage-secreted
factors on transfection of airway epithelial cells and
to simulate the environment of the epithelial cell in
CF (in£amed) lungs, H441 cells were transfected
after the addition of conditioned macrophage me-
dium. After making a one-third dilution of condi-
tioned medium using serum-free RPMI, the mixture
(4 ml) was added to the H441 cell cultures prior to
addition of lipoplex.
For determination of the e¡ects of direct addition
of speci¢c cytokines on transfection e⁄ciency of
H441 cells, each cytokine was separately added to
H441 cells in isolated culture. Speci¢cally, TNF-K,
interferon-Q (recombinant human IFN-Q ; 10 ng/ml,
RpD Systems), IL-6, or IL-8 (recombinant human
IL-8, 10 ng/ml; Collaborative Biomedical Products,
Bedford, MA) were added to H441 cells (at the con-
centrations given above, unless speci¢ed otherwise)
30 min prior to transfection. For TNF-K neutraliza-
tion experiments, mouse anti-recombinant human
TNF-K antibody (Upstate Biotechnology, Lake Plac-
id, NY) was added at a concentration of 1.5 Wg/ml to
H441 cells in isolated cultures immediately following
addition of TNF-K at 0.1 ng/ml or at various times
after addition of TNF-K, as indicated. Mouse anti-
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human IL-8 antibody (Upstate Biotechnology) was
used as an irrelevant antibody control.
2.7. CAT assays
CAT assays were performed for co-culture experi-
ments only as described previously [18]. Brie£y, cel-
lular pellets obtained after transfection were sus-
pended in 0.25 M Tris at pH 7.8, lysed by two
freeze/thaw cycles and heated at 65‡C for 5 min.
Cellular debris was removed by centrifugation and
the supernatant volumes normalized to protein con-
tent (via BCA total protein assay, Pierce, Rockford,
IL). CAT assays were performed with cell extracts in
500 mM Tris bu¡er at pH 7.8, and incubated for 2 h
with 4 mM acetyl-CoA and 0.1 WCi of 14C-chloram-
phenicol. Plates were imaged on a Phosphor Imager,
and the percentage of acetylation products calculated
using ImageQuant software. Results are reported as
percent conversion of chloramphenicol to acetylated
products with normalization to total cellular protein.
2.8. Luciferase assays
After ¢nal incubation, cells were lysed by a lysis
bu¡er (Promega). Cellular debris was removed by
centrifugation and the supernatant volumes normal-
ized to protein content (via BCA total protein assay;
Pierce). Expression of the transfected luciferase was
analyzed by the Promega Luciferase Assay System
with normalization to total cellular protein (BCA
total protein assay). Each condition was run in trip-
licate (minimally) and is reported as relative light
units (RLU)/Wg total cellular protein or as percent
of control luciferase activity ([RLU/Wg cellular
protein]sample/[RLU/Wg cellular protein]controlU100).
Cell viability, as measured by cell proliferation, was
determined under each condition using Cell Titer
AQ-96 (Promega). All data are expressed as mean þ
S.E.M. with signi¢cance set at P6 0.05 (paired Stu-
dent’s t-test).
2.9. Formulation of lipofectin-DNA complexes for
£uorescence microscopy
Initially, Lipofectin (Gibco) was lyophilized and
redissolved in 1:1 methanol/chloroform (v/v). To
this solution was added an appropriate volume of
BODIPY-PE (Molecular Probes, Eugene, OR) in
chloroform to achieve a molar ratio of 1:500 (£uo-
rescent probe to lipid). The organic solvent was elim-
inated in vacuo and the complexes were suspended in
PBS as 1 mg/ml suspensions via sonication. BODI-
PY-PE:lipoplexes were formulated using a weight
ratio of 1 Wg DNA to 10 Wg lipid (charge ratio of
0.8). The plasmid utilized for co-culture experiments
was pCMV-luc. BODIPY-PE-labeled lipoplex and
lysosome-speci¢c £uorescent dye Lysosensor green
(Molecular Probes) were added to cell cultures and
cultures were incubated with the complex for 2 h.
Immediately following this incubation period, cells
were washed three times with PBS prior to ¢xation
as described below.
2.10. Epi£uorescence microscopy
Prior to microscopy, cells were ¢xed using 5%
paraformaldehyde and coated with 0.5 ml PBS. Im-
ages were acquired using a Zeiss Axioscope micro-
scope with a 40U NeoFlur objective. Texas red and
FITC excitation/emission ¢lter sets were used for de-
tection of BODIPY-PE and Lysosensor green, re-
spectively. Scion Image (Scion, Frederick, MA) en-
abled capture and analysis of images. A minimum of
four images was acquired from each sample.
3. Results
The design of the following experiments was based
on observations from preliminary AM/H441 co-cul-
ture experiments that addressed the e¡ects of the
physical presence of rabbit AMs on transfection of
H441 cells. In those co-culture experiments, which
used the chloramphenicol acetyltransferase gene as
the reporter gene, the presence of Con A-activated
macrophages in co-culture with H441 cells resulted in
an astounding 85% reduction in CAT activity of
H441 cells vs. isolated H441 cell culture controls
(data not shown). This reduction in transfection
could be the result of (1) macrophage-secreted fac-
tors a¡ecting transgene uptake, routing or expression
by H441 cells, or (2) loss of lipid-DNA complex to
macrophage phagocytosis, or (3) a combination of
both of these processes. By using isolated cultures
of H441 cells, the experiments described henceforth
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focus on the hypothesis that macrophage-secreted
factors and speci¢c cytokines regulate cationic lip-
id-mediated transfection of model airway cells.
Incubation of H441 cells in isolated culture with
conditioned macrophage medium was performed to
test the hypothesis that cytokines secreted by macro-
phages have inhibitory e¡ects on transfection of air-
way epithelial cells. In contrast to the co-culture ex-
periments, this set of experiments would eliminate
e¡ects in transfection e⁄ciency arising from phago-
cytosis or adherence of lipoplex to macrophages. Me-
dium obtained from macrophage cultures exposed to
macrophage activators (aAMs) or cytokines (cyt-
AMs) was added to H441 cells prior to transfection
with lipoplex. Medium from macrophages activated
by one of the established activators of macrophage
function (STZ, Con A, or LPS) led to varying de-
grees of decreased transfection of H441 cells as re-
£ected by reductions in luciferase activity (Fig. 1).
STZ-aAM medium resulted in the largest decrease
in luciferase activity (transfection e⁄ciency) yielding
an 80% reduction in luciferase activity with respect to
lipoplex controls. A 50% reduction in luciferase ac-
tivity was observed for H441 cells transfected in the
presence of Con A-activated macrophage medium,
while LPS-aAMs medium e¡ected a reduction in lu-
ciferase activity of approx. 20% vs. controls. In con-
trast to the action of the macrophage activators,
when either IL-6 or TNF-K cytAM medium was
added to H441 cell cultures prior to transfection,
no signi¢cant changes in luciferase activity resulted
with respect to control wtAM medium.
Speci¢c cytokines (secreted by activated macro-
phages or epithelial cells during in£ammation) were
added directly to H441 cells in isolated cultures with
the aim of determining the e¡ects of each factor on
the e⁄ciency of DNA transfection of H441 cells.
Results of direct addition experiments are illustrated
in Fig. 2 and are reported as percent of control (lipo-
plex only added to H441 cells). Of the cytokines
applied directly to H441 cells, direct addition of the
cytokine IL-6 or IL-8 to H441 cell cultures had no
signi¢cant e¡ects on luciferase activity with respect
to the control.
TNF-K and IFN-Q, on the other hand, inhibited
Lipofectin-mediated transfection when added indi-
vidually or in combination to H441 cells. Direct ad-
dition of 0.2 ng/ml TNF-K to H441 cells in isolated
culture resulted in a substantial decrease in luciferase
Fig. 2. E¡ects of direct addition of cytokines TNF-K, IFN-Q
IL-6 or IL-8 on transfection e⁄ciency of H441 cells in vitro.
H441 cells in isolated culture were transfected with luciferase
reporter gene construct in the presence of the indicated factors.
Data for e¡ects of each direct addition were normalized to con-
trol (lipoplex only) values and are reported as percent of con-
trol. Error bars represent þ 1 S.E.M.; n = 4; *P6 0.01.
Fig. 1. E¡ect of conditioned macrophage medium on transfec-
tion e⁄ciency of H441 cells in vitro. Wild type alveolar macro-
phages were incubated in the presence of macrophage activators
(STZ, Con A or LPS) to yield aAMs or cytokines (IL-6 and
TNF-K) to yield cytAMs. CytAM medium or aAM medium
was then added to H441 cell cultures in isolated culture prior
to transfection with lipoplexes. Results of luciferase assays
examining the e¡ects of each conditioned AM medium were
normalized to values from exposure of H441 cells to wtAM
medium and reported as % of control. Error bars represent
þ 1 S.E.M.; n = 4; *P6 0.05.
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activity, to a value that was reduced by more than
80% of the control value, whereas IFN-Q (10 ng/ml)
added directly reduced transfection e⁄ciency by 65%
vs. controls (Fig. 2). Interestingly, when TNF-K and
INF-Q were added simultaneously, a cumulative inhi-
bition of transfection was observed. The inhibitory
e¡ect of TNF-K on transfection e⁄ciency in H441
cells was dose-dependent over a TNF-K concentra-
tion range of 0.1^1.5 ng/ml (Fig. 3), with the largest
drop in e⁄ciency occurring between TNF-K concen-
trations of 0 and 0.1 ng/ml. As the concentration was
increased above 0.5 ng/ml TNF-K, only modest, ad-
ditional decreases in luciferase activity were ob-
served. Inhibition of transfection e⁄ciency was max-
imal when TNF-K (at 0.1 ng/ml) was added to the
cultures at the same time as the lipoplex (time zero)
and was moderately decreased (increase in luciferase
activity) when TNF-K was added at 0.5, 2, 4 or 8 h
post lipoplex addition (Fig. 4).
To examine the speci¢city of TNF-K-dependent
inhibition of transfection e⁄ciency, the same experi-
ment was performed in the presence of mouse neu-
tralizing anti-recombinant human TNF-K monoclo-
nal antibody. As shown in Fig. 5, anti-TNF-K
antibody neutralized the inhibitory e¡ects of TNF-
K on transfection when added at either the same time
(time zero) or 30 min following the addition of TNF-
K and lipoplex. At these two time points the lucifer-
ase activity returned to approx. 82% of the control
Fig. 5. Neutralization of TNF-K with neutralizing monoclonal
antibodies results in the recovery of luciferase activity and is
dependent upon time of antibody addition. Anti-recombinant
human TNF-K antibody was added at time zero or various
times after addition of TNF-K and lipoplex to H441 cell cul-
tures (8). Controls include: lipoplex, but no TNF-K or anti-
TNF-K antibody, R ; lipoplex and TNF-K only, F ; lipoplex
and anti-TNF-K antibody only, b. Results for each time point
were normalized to total cellular protein and reported as rela-
tive light units/Wg total cellular protein. Error bars represent þ 1
S.E.M. of three replicate measurements.
Fig. 4. E¡ect of time of TNF-K addition on inhibition of trans-
fection e⁄ciency as measured by luciferase activity. TNF-K was
added to H441 cell cultures at various times following addition
of lipoplex (8) ; lipoplex only (no TNF-K added) served as
control (F). Results were normalized to cellular protein concen-
tration and reported as relative light units/Wg total cellular pro-
tein. Error bars represent þ 1 S.E.M. of four replicates per
point.
Fig. 3. E¡ect of TNF-K concentration on luciferase activity.
TNF-K was added to H441 cell cultures at concentrations of
0.1, 0.5, 1.0 and 1.5 ng/ml in RPMI medium immediately be-
fore addition of lipoplex. Data for e¡ects of each direct addi-
tion were normalized to total cellular protein and reported as
relative light units/Wg total cellular protein. Error bars represent
the S.E.M. of four replicates per point.
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value (no TNF-K), in comparison to 44% of the con-
trol value for TNF-K in the absence of antibody. The
ability of the anti-TNF-K antibody to neutralize the
inhibitory e¡ects of TNF-K was diminished when the
antibody was added 2 h or longer after the onset of
transfection. When antibody was added at either 4 or
8 h after TNF-K and lipoplex minimal neutralization
of TNF-K was observed with respect to TNF-K con-
trol. Transfection experiments performed in the pres-
ence of anti-TNF-K monoclonal antibody alone ex-
hibited only a slight (approx. 5%) reduction in
transfection e⁄ciency.
Lipoplex containing small amounts of BODIPY-
PE, a £uorescent adduct of dioleoylphosphatidyl-
ethanolamine was endocytosed by H44 cells within
a 2 h incubation period in the absence of TNF-K, as
illustrated in Fig. 6A. However, in the presence of
TNF-K, the relative amount of £uorescent lipoplex in
the cell was signi¢cantly reduced following a 2 h
incubation of cells with lipoplex and TNF-K, as in-
dicated by the low £uorescence signal in Fig. 6B.
These results are consistent with the hypothesis that
endocytosis of lipoplex is being a¡ected by TNF-K.
The relative number of lysosomes, as indicated by
Lysosensor green (Fig. 6B,D), did not appear to be
a¡ected by the addition of TNF-K.
Cell proliferation assays, which indirectly yield in-
formation of H441 cell viability, were performed to
ascertain that the conditioned macrophage media or
directly added cytokines were not causing cell death,
thereby decreasing transfection e⁄ciencies. Since the
luciferase assays were performed on cells isolated
after 48 h exposure to Lipofectin and speci¢c cyto-
kines, viability was examined at 24, 48 and 72 h after
addition of the factors. In all cases, H441 cell viabil-
ity was not compromised signi¢cantly by any of the
Fig. 6. TNF-K alters endocytosis of lipoplex in H441 cells. Endocytosis of lipoplex in the presence and BODIPY-PE-labeled lipoplex
by H441 cells in the absence (A) and presence (C) of TNF-K is illustrated as detected by £uorescence microscopy. Fluorescence of
Lysosensor green was used to indicate the presence of lysosomes in the H441 cells, as indicated by the punctate domains, in the ab-
sence (B) and presence (D) of TNF-K.
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conditioned macrophage media or speci¢c cytokines
(data not shown).
4. Discussion
The experiments presented in this paper are the
¢rst to demonstrate the inhibitory e¡ect of medium
obtained from activated macrophages and TNF-K on
cationic liposome-mediated gene transfection of air-
way cells in vitro. The e¡ects of medium from con-
ditioned macrophages and speci¢c cytokines on
transfection e⁄ciency of H441 model airway epithe-
lial cells were examined. The biochemical environ-
ments established for the H441 cells in these experi-
ments more closely simulate those of the pulmonary
epithelial cells in CF lungs (as compared to those of
typical protein-free in vitro transfection experi-
ments), where the number of macrophages and neu-
trophils are elevated above normal values.
Determination of the e¡ects of in£ammatory cyto-
kines on CLip-mediated gene therapy will be essen-
tial for the development of e¡ective CLip delivery
vehicles for use in genetic correction of diseases
with underlying in£ammation, whether CF or other
diseases. Results of preliminary transfection assays
for H441 cells in co-culture with alveolar macro-
phages demonstrated that the physical presence of
macrophages signi¢cantly reduced RSV/CAT DNA
transfection. Losses in transfection e⁄ciency for
H441 cells associated with the presence of AMs
may be attributed to (1) phagocytosis of DNA-Lipo-
fectin complexes by AMs or (2) substances secreted
by macrophages that inhibit DNA expression or up-
take by H441 cells. In£uences of macrophage-se-
creted substances on transfection e⁄ciency were ex-
amined directly by incubating H441 cells in isolated
culture with medium obtained from wtAMS and
aAMs, and indirectly by adding speci¢c recombinant
human cytokines H441 cells in isolated culture.
These experiments eliminated potential decreases in
transfection e⁄ciency because of loss of lipoplex to
macrophage phagocytosis. Thus, decreases in trans-
fection e⁄ciency were derived from actions of aAM-
secreted bioactive molecules (conditioned medium
experiments) or speci¢c cytokines (direct addition
of recombinant cytokines).
TNF-K, which is secreted primarily by macro-
phages, is one of a few cytokines that appears in
signi¢cantly increased amounts in CF lungs [9,19].
Direct addition of TNF-K to H441 cells prior to in-
cubation with lipoplex caused up to a 5-fold decrease
in luciferase activity depending on concentration,
and did not a¡ect cell viability. A maximal decrease
in luciferase activity occurred when TNF-K was
present at the time of lipoplex addition, with a
slightly attenuated but fairly constant inhibition of
transfection when TNF-K was added 30 min^8 h
after lipoplex addition. A complete recovery of trans-
fection e⁄ciency with respect to control values upon
neutralization of TNF-K by neutralizing antibody
speci¢c for TNF-K is indicative of a speci¢c e¡ect
of TNF-K on transfection, rather than a generalized
e¡ect, such as coating (adsorption) of the protein to
cells. Temporal addition of anti-recombinant TNF-K
antibody was a critical factor with respect to its abil-
ity to neutralize the inhibitory e¡ects of TNF-K.
Antibody added within the ¢rst 2 h of transfection
in the presence of TNF-K neutralized the inhibitory
e¡ects of TNF-K on transfection. In conjunction
with time of TNF-K addition vs. luciferase activity
(Fig. 4), results of antibody neutralization of TNF-K
indicate that inhibitory e¡ects of TNF-K on trans-
fection of H441 cells may stem from events that oc-
cur within the ¢rst 2 h of transfection. These results
are also consistent with the premise that TNF-K in
CF lungs may precipitate a reduction in transfection
e⁄ciency of airway epithelial cells. Taken together
with results of the £uorescence microscopy experi-
ments, the ¢ndings presented herein are consistent
with the hypothesis that TNF-K alters endocytosis
of lipoplex in model airway cells, thus reducing
transfection e⁄ciency.
In contrast to the e¡ects of TNF-K, direct addition
of IL-8 or IL-6 to H441 cells in isolated cultures
prior to lipoplex did not alter the transfection e⁄-
ciency of these cells. IL-8 primarily a¡ects endothe-
lial cells and neutrophils, rather than epithelial cells
[8,20], and as is shown by these data, is not likely to
directly a¡ect uptake, routing or expression of the
Lipofectin-delivered DNA. Interleukin-6, a pleiotro-
pic proin£ammatory cytokine which is secreted by
airway epithelial cells and macrophages, acts to in-
duce immunoglobulin production and macrophage
di¡erentiation [21]. Since its principal target cells
are B-lymphocytes and macrophages, no e¡ect of
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IL-6 on transfection e⁄ciency of H441 cells would be
expected, as was observed. Results presented here
indicate that although IL-6 is capable of inducing
macrophage di¡erentiation, it does not promote se-
cretion of products by macrophages that interfere
with transfection of the H441 cells.
E⁄cient uptake and routing (endocytosis) is essen-
tial for successful transfection. Cationic liposomes
consisting of DOTMA, DOTAP (dioleoyltrimeth-
ylammonium propane) or DC-CHOL (3L-(N-
(NP,NP-dimethylaminoethane)carbamoyl) cholesterol)
have been shown to be taken up by cells in vitro
through endocytic pathways [13,14]. Speci¢c path-
ways that lead to transgene expression, including nu-
clear routing and separation of DNA from lipoplex,
have not yet been delineated. Although factors that
control endocytosis of these cationic lipids have not
been studied, mechanisms of cellular uptake of other
molecules are controlled by in£ammatory cytokines,
such as TNF-K, and the e¡ect on endocytosis or
phagocytosis in vitro depends on cell type and li-
gand. For instance, exposure of bovine brain capil-
lary endothelial cells to TNF-K resulted in opposing
regulation of low density lipoprotein (LDL) and
transferrin (Tfn) receptor-mediated endocytosis, in
which LDL endocytosis increases and Tfn endocyto-
sis decreases [11]. Rainard and Poutrel have demon-
strated that phagocytosis of opsonized S. agalactiae
by bovine neutrophils is enhanced by TNF-K and
complement C5a in vitro [10].
Routing of endocytosed molecules can also be
a¡ected by TNF-K. In studies by Martinez et al.
TNF-K was shown to alter routing of formalde-
hyde-treated bovine serum albumin following endo-
cytosis, as indicated by the increased rate by which
the ligand was transported to lysosomes [22]. Trans-
cytosis of both Tfn and LDL across brain capillary
endothelial cells in vitro has been shown to be en-
hanced upon exposure of the cells to TNF-K [11].
Hence, the ability of TNF-K to in£uence the lysoso-
mal fate of cationic liposomes, if it were to occur,
would have a signi¢cant negative impact on e¡ective-
ness and e⁄ciency of gene therapy during in£amma-
tion in vivo. The £uorescence data demonstrating
reduced £uorescence from BODIPY-PE-labeled
lipoplex is consistent with both TNF-K-dependent
inhibited uptake and/or TNF-K-dependent enhance-
ment of lysosomal routing of lipoplex, thus reducing
the amount of lipoplex available for nuclear rout-
ing.
Viral promoters used for enhanced expression of
transgene in several cell lines in vitro have been
shown to be negatively a¡ected by in£ammatory cy-
tokines, leading to inhibition of transgene expression.
Harms and Splitter demonstrated that IFN-Q inhibits
transgene expression in a variety of non-airway cells
when SV40 or CMV promoters are utilized [23]. Qin
et al. demonstrated that stably transfected myoblasts
incubated in the presence of TNF-K and IFN-Q alone
or in combination inhibit expression of transgene
driven by viral promoters [24]. Although those stud-
ies focused on non-airway cell lines, such inhibition
may play an important role for the design of vectors
for in vivo transfection of airway cells, if vectors
containing viral promoters continue to be used.
However, the results of our studies indicate that
TNF-K a¡ects transfection at phases that occur ear-
lier than transgene expression in model airway cells,
speci¢cally endocytosis of lipoplex.
In theory, these data in combination with previ-
ously published reports of in£ammatory cytokine in-
hibition of transgene expression driven by viral pro-
moters would indicate accumulative inhibitory e¡ects
of TNF-K on transfection e⁄ciency [24]. Transgene
uptake and/or routing and/or expression in airway
cells under conditions of in£ammation in vivo would
be expected to be negatively controlled by TNF-K ;
nevertheless, a correlation between the present in vi-
tro studies and the in vivo outcome has yet to be
established.
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